AVANÇOS CLÍNICOS NO USO DE PSICODÉLICOS PARA TRANSTORNOS PSIQUIÁTRICOS: UMA REVISÃO INTEGRATIVA
Alberto Almeida, Carlos Paulo da Silva, Clara Guerzoni, Ederaldo Oliveira, Edis Rodrigues Junior, Guilherme Mesquita, Higor Ruan Rosa, Izabela Christina Magalhães Malta Dionisio, Janaina Luiza Thomé, Karine Luz, Kayra Batista, Suellen Borges, Tânia Martin Guilherme, V.D.R. Dias, Weveson Tavares
Revista fisio&terapia. August 15, 2024 DOI: 10.69849/revistaft/ni10202408151406 via OpenAlex
Summary
AI-generated from the abstractAn integrative review examines the use of psychedelics in psychiatry, covering their historical promise in the 1950s–1970s, subsequent decline due to restrictive policies and stigma, and a recent resurgence driven by new research and changing public perceptions. The review discusses mechanisms of action and neuroplasticity induced by psychedelics, integrative therapeutic approaches, and associated risks and ethical challenges. Compared to traditional treatments that are often ineffective or have significant side effects, psychedelics show potential effectiveness for depression, PTSD, and anxiety. The future appears promising, with research advancements and regulatory changes potentially expanding clinical applications.
Study at a glance
| Characteristics | Integrative review Peer reviewed |
|---|---|
| Topics | Anxiety |
| Keywords | Psychotherapist Context archaeology Psychology Clinical practice |
| Key finding | Psychedelics show potential effectiveness for treating depression, PTSD, and anxiety compared to traditional treatments. |
Abstract
This integrative review explores the use of psychedelics in psychiatry, focusing on their historical context, recent resurgence, and clinical efficacy in treating psychiatric disorders such as depression, PTSD, and anxiety. Initially, psychedelic therapies showed promise in the 1950s and 1970s but were diminished due to restrictive policies and stigma. However, a resurgence in clinical interest has been driven by new research and changing public perceptions, highlighting the potential effectiveness of psychedelics compared to traditional treatments, which are often ineffective or have significant side effects. The review discusses the mechanisms of action and neuroplasticity induced by psychedelics, integrative therapeutic approaches, and the associated risks and ethical challenges. The future of psychedelic therapies appears promising, with advancements in research and regulatory changes potentially expanding their clinical applications. The review concludes with a reflection on clinical practice implications and suggestions for future research areas.